These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11803472

  • 1. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
    Bowe DB, Kenney NJ, Adereth Y, Maroulakou IG.
    Oncogene; 2002 Jan 10; 21(2):291-8. PubMed ID: 11803472
    [Abstract] [Full Text] [Related]

  • 2. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.
    Cancer Res; 2003 Jun 15; 63(12):3395-402. PubMed ID: 12810676
    [Abstract] [Full Text] [Related]

  • 5. Requirement for CDK4 kinase function in breast cancer.
    Yu Q, Sicinska E, Geng Y, Ahnström M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, Stål O, Sicinski P.
    Cancer Cell; 2006 Jan 15; 9(1):23-32. PubMed ID: 16413469
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 8. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M, Rodriguez O, Pootrakul L, Aventian M, Lushina N, Cromelin C, Ferzli G, Johnson K, Fricke S, Diba F, Kallakury B, Ohanyerenwa C, Chen M, Ostrowski M, Hung MC, Rabbani SA, Datar R, Cote R, Pestell R, Albanese C.
    Cancer Res; 2007 May 01; 67(9):4364-72. PubMed ID: 17483350
    [Abstract] [Full Text] [Related]

  • 9. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.
    Cancer Res; 2007 Sep 15; 67(18):8671-81. PubMed ID: 17875707
    [Abstract] [Full Text] [Related]

  • 10. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
    Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW.
    Cancer Cell; 2006 Jan 15; 9(1):13-22. PubMed ID: 16413468
    [Abstract] [Full Text] [Related]

  • 11. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
    Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV.
    Nature; 1994 Jun 23; 369(6482):669-71. PubMed ID: 8208295
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.
    Cancer Res; 2007 Aug 01; 67(15):7212-22. PubMed ID: 17671189
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ.
    Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX.
    Oncogene; 2001 Mar 22; 20(12):1445-54. PubMed ID: 11313888
    [Abstract] [Full Text] [Related]

  • 15. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
    Kuang SQ, Liao L, Wang S, Medina D, O'Malley BW, Xu J.
    Cancer Res; 2005 Sep 01; 65(17):7993-8002. PubMed ID: 16140972
    [Abstract] [Full Text] [Related]

  • 16. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
    Bentires-Alj M, Neel BG.
    Cancer Res; 2007 Mar 15; 67(6):2420-4. PubMed ID: 17347513
    [Abstract] [Full Text] [Related]

  • 17. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J, Rajput AB, Lu H, Sanguin-Gendreau V, Zuo D, Papavasiliou V, Lavoie C, Turpin J, Cianflone K, Huntsman DG, Muller WJ.
    Mol Cell Biol; 2007 Sep 15; 27(18):6361-71. PubMed ID: 17636013
    [Abstract] [Full Text] [Related]

  • 18. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 19. Cyclin d1 overexpression sensitizes breast cancer cells to fenretinide.
    Pirkmaier A, Yuen K, Hendley J, O'Connell MJ, Germain D.
    Clin Cancer Res; 2003 May 01; 9(5):1877-84. PubMed ID: 12738746
    [Abstract] [Full Text] [Related]

  • 20. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.
    Reddy HK, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP.
    Cancer Res; 2005 Nov 15; 65(22):10174-8. PubMed ID: 16288002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.